Sex, Race, and Geographic Location Affect HIV Vaccine Efficacy
A recent study on the Immune System Diseases and Conditions - HIV/AIDS has shed light on how sex, race, and geographic location may influence the effectiveness of HIV vaccines. The research, conducted by LMU University Hospital, involved a randomized, double-blinded, placebo-controlled phase 2 trial that enrolled 480 Black and Caucasian adults from Africa and the Americas. The study aimed to examine the role of these factors on vaccine-induced HIV-specific immune responses within the HVTN 204 trial.
Key Takeaways:
- The study found that Envelope-specific antibody titers were significantly increased for IgG1 but reduced for IgA in females compared to males, four weeks post-final vaccination boost.
- The research concluded that understanding biological factors driving these sex-based differences may improve the design of a new generation of HIV vaccine candidates.
- The study enrolled 480 Black and Caucasian adults from Africa and the Americas, with 85 Black participants (59% female) and 49 Caucasian participants (51% female).
- The study used an Enzyme-Linked Immunosorbent Assay to determine titers of Envelope-specific IgG1, IgG3, and IgA antibodies in available serum samples.
- Recognition of linear Envelope peptide-specific IgG responses was mapped in a randomly selected subgroup analysis using a custom-designed peptide microarray.
- Associations between vaccine-induced Envelope-specific antibody responses and sex assigned at birth (female or male), race, and geographic location were analyzed by the Mann-Whitney U test, Fisher's exact test, and multivariate logistic regression.
Statistics:
- 480 participants enrolled in the study, with 85 Black participants and 49 Caucasian participants.
- 59% of Black participants were female, and 51% of Caucasian participants were female.
- Envelope-specific antibody titers were significantly increased for IgG1 in females (900 vs. 300 median titer, p=0.030).
- Envelope-specific antibody titers were reduced for IgA in females (p=0.030).
Sources:
- Effects of sex but not race and geographic origin on vaccine-induced HIV-specific antibody responses. Frontiers in Immunology, 2025;16:1601865.
- Frontiers Media Sa, Avenue Du Tribunal Federal 34, Lausanne, Ch-1015, Switzerland.
- Contact information for additional information: Augusta Horvath, Institute of Infectious Diseases and Tropical Medicine, LMU University Hospital, LMU Munich, Munich, Germany.
- Keywords: Antibodies, Munich, Europe, Germany, Genetics, HIV/AIDS, Vaccines, Virology, Immunology, RNA Viruses, Vaccination, Retroviridae, Blood Proteins, Immunoglobulins, Biological Factors, Vertebrate Viruses, Biological Products, Health and Medicine, Primate Lentiviruses, Immunization and Public Health.